Multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Placebo
Capsules of evening primrose oil 1 g orally 2 times a day for 3 months in the intervention group
1 gram oral placebo capsules 2 times a day for 3 months in the control group
Manufacturer: Barij Essence
Intervention 1: Capsules of evening primrose oil 1 g orally 2 times a day for 3 months in the intervention group. Intervention 2: 1 gram oral placebo capsules 2 times a day for 3 months in the control
Treatment - Drugs
Sponsors
Vice Chancellor For Research Of Jundishapur University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) The diagnosis of the neurological examination and magnetic resonance imaging confirmed by a doctor neurologist is sent. 2) persons 15-55 years 3) EDSS score of less than 6, 4) neurological diseases such as stroke or psychiatric, such as depression or not. 5) pregnant women are not tested. 6) autoimmune diseases like lupus or rheumatoid arthritis, and heart as Bdkhymy- not. 7) patients in the last month attack (attack) is not new and they did not use the pulse corticosteroids.";" Exclusion criteria: 1) the emergence of drug complications 2) resentment of the presence in the study 3) of the drug for a week 4) Pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before and 3 months after intervention. Method of measurement: Quality of Life in this study using a questionnaire with 54 questions were Vickrey and colleagues. sclerosis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue. Timepoint: Before and 3 months after intervention. Method of measurement: MFIS was measured using the scale of fatigue in multiple sclerosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNastaran Majdinasab
Jundishapur University Of Medical Sciences
Outcome results
None listed